Stiris Research Inc. Announces Our Newest Director, Clinical Science

London, ON — September 29, 2021 —

Stiris Research (“Stiris”) an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, today announced the addition of Tazrina Alrazi, MD, PhD, MSc (MBA, PMP) to the Clinical Science team.

Tazrina is a medically trained physician, who continued her education to obtain her Master’s and Ph.D. in Clinical Neuroscience, with a focus on brain mechanisms in patients with mild cognitive impairment and the diagnosis of early dementia. She is passionate about education, teaching and mentoring, and values the patients’ stories. While in academia, she valued the proper interpretation of data and mentored different groups about good scientific communication. Tazrina is a patient-focused neuroscientist who thrives in solving scientific problems that optimizes clinical trial outcomes.

“Within the first 5 minutes of my initial discussion with Tazrina, it was evident how close her values are to Stiris’. Everything she has accomplished in her career is all about making a difference in the world,” said Carrie Hamilton, Senior Director, Clinical Science

In addition to her educational successes, Tazrina has also worked in Clinical Operations, Business Development and as a Medical Advisor on various clinical trials with experience in North America and internationally. Her experience includes drug and medical device development in neurology (movement disorders, dementia, diabetes, aging, cognitive impairment, neuropsychology, neurobehavior), immunology, dermatology, pain management, cloud-based and software technology, and other data-based technology platforms. She is an expert in neuroimaging and behavioral assessments. Her focus and strengths are in CNS, Diagnostics and Devices which will undoubtedly enhance and elevate our Clinical Science group.

About Stiris Research

Stiris Research is an entrepreneurial Clinical Trial Management company specializing in conducting complex Phase I through IIIB trials for North American biotechnology and biopharmaceutical companies, with a focus on Oncology, CNS and Neurology. Stiris Research was formed as a result of listening to the stakeholders engaged in clinical trials, identifying their unmet needs, and developing a unique, value-based approach to address those needs.

For more information, please contact:

Marketing – Stiris Research Inc.